Bristol-Myers Squibb
BMY
#173
Rank
โ‚ฌ104.96 B
Marketcap
51,54ย โ‚ฌ
Share price
0.60%
Change (1 day)
-0.96%
Change (1 year)

Revenue for Bristol-Myers Squibb (BMY)

Revenue in 2024: โ‚ฌ46.41 Billion

According to Bristol-Myers Squibb's latest financial reports the company's current revenue (TTM ) is โ‚ฌ40.81 Billion. In 2024 the company made a revenue of โ‚ฌ46.41 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ40.71 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bristol-Myers Squibb from 1996 to 2024

Annual revenue

Year Revenue Change
2024โ‚ฌ46.41 B14.01%
2023โ‚ฌ40.71 B-5.39%
2022โ‚ฌ43.03 B5.06%
2021โ‚ฌ40.95 B18.49%
2020โ‚ฌ34.56 B48.11%
2019โ‚ฌ23.33 B18.34%
2018โ‚ฌ19.72 B13.89%
2017โ‚ฌ17.31 B-6.25%
2016โ‚ฌ18.46 B21.95%
2015โ‚ฌ15.14 B16%
2014โ‚ฌ13.05 B10.04%
2013โ‚ฌ11.86 B-10.94%
2012โ‚ฌ13.32 B-18.57%
2011โ‚ฌ16.35 B11.68%
2010โ‚ฌ14.64 B25.69%
2009โ‚ฌ11.65 B-20.9%
2008โ‚ฌ14.73 B17.66%
2007โ‚ฌ12.52 B-7.77%
2006โ‚ฌ13.57 B-16.27%
2005โ‚ฌ16.21 B25.22%
2004โ‚ฌ12.94 B-22.45%
2003โ‚ฌ16.69 B-3.66%
2002โ‚ฌ17.33 B-20.19%
2001โ‚ฌ21.71 B7.27%
2000โ‚ฌ20.24 B5.17%
1999โ‚ฌ19.25 B24.94%
1998โ‚ฌ15.40 B9.48%
1997โ‚ฌ14.07 B10.86%
1996โ‚ฌ12.69 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ78.29 B 91.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.15 B 17.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ53.34 B 30.71%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ50.67 B 24.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ50.48 B 23.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ30.56 B-25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ40.38 B-1.06%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚ฌ8.55 B-79.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ54.57 B 33.73%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ49.38 B 21.01%๐Ÿ‡ฌ๐Ÿ‡ง UK